Table 4.
Characteristics of studies Group 2 (BOP + probing depth ≥ 6 mm + bone loss ≥ 2 mm)
| Studies | Characteristics | Results | ||||||
|---|---|---|---|---|---|---|---|---|
| Population | Sample (N)(P) | Sample (N)(DI) | Design follow-up | Time load (Y) | Diagnostic | Rate (P) (%) | Rate(DI) (%) | |
| Gamper [38] | EU | 56 | 143 | Randomized Controlled Trial | 5 | BOP/suppuration + PD ≥ 5 mm + BL ≥ 2 mm | 10.7143 | 7.6923 |
| Gatti [39] | EU | 56 | 227 | Cohort | 5 | BOP/suppuration + PD > 5 mm + BL > 2 mm | 3.5714 | 1.7621 |
| Gonzalez-Glez (2020) | EU | 65 | 558 | Longitudinal | 5 | BOP/suppuration + PD ≥ 5 mm + BL > 2 mm | 16.9231 | 1.9713 |
| Guarneri (2018) | EU | 74 | 166 | Longitudinal | 5 | BOP/suppuration + PD > 5 mm + BL > 2 mm | 13.5135 | 7.8313 |
| Hu [42] | Singapore | 200 | 284 | Cohort | 6.8 | BOP/ + incr PD + BL > 2 | 13 | 10.2113 |
| Ioannidis[43] | EU | 64 | 103 | Randomized Controlled Trial | 5 | BOP + BL > 2 mm | Missing | 6.7961 |
| Karlsson[44] | EU | 596 | Missing | Cohort | 9 | BOP/suppuration + BL > 2 mm | 18.4564 | Missing |
| Kosdsland (2010) | EU | 104 | 295 | Cross-sectional | 8.4 + 4.6 | BOP/suppuration + PD ≥ 4 mm + BL ≥ 2 mm | 47.1154 | 36.6102 |
| Konstantinidis [46] | EU | 90 | 226 | Cross-sectional | 5.5 | BOP + PD > 5 mm + BL > 2 mm | 13.3333 | 6.1947 |